Clorox Co (NYSE:CLX) Position Cut by New Mexico Educational Retirement Board

Share on StockTwits

New Mexico Educational Retirement Board trimmed its holdings in Clorox Co (NYSE:CLX) by 1.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,475 shares of the company’s stock after selling 200 shares during the quarter. New Mexico Educational Retirement Board’s holdings in Clorox were worth $1,604,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Dimensional Fund Advisors LP boosted its position in shares of Clorox by 8.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 582,745 shares of the company’s stock worth $89,822,000 after buying an additional 45,408 shares during the period. Geode Capital Management LLC boosted its position in shares of Clorox by 21.5% in the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock worth $292,347,000 after buying an additional 335,835 shares during the period. Millennium Management LLC boosted its position in shares of Clorox by 323.7% in the fourth quarter. Millennium Management LLC now owns 6,643 shares of the company’s stock worth $1,024,000 after buying an additional 9,613 shares during the period. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Clorox in the first quarter worth about $934,000. Finally, Oppenheimer & Co. Inc. lifted its stake in shares of Clorox by 8.3% in the first quarter. Oppenheimer & Co. Inc. now owns 16,439 shares of the company’s stock worth $2,638,000 after acquiring an additional 1,254 shares in the last quarter. 75.88% of the stock is owned by institutional investors and hedge funds.

In related news, SVP Michael R. Costello sold 3,225 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $161.34, for a total value of $520,321.50. Following the completion of the transaction, the senior vice president now directly owns 29,669 shares of the company’s stock, valued at approximately $4,786,796.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Denise Garner sold 20,399 shares of the stock in a transaction that occurred on Friday, June 7th. The stock was sold at an average price of $157.61, for a total value of $3,215,086.39. Following the completion of the transaction, the senior vice president now directly owns 4,896 shares of the company’s stock, valued at $771,658.56. The disclosure for this sale can be found here. Insiders have sold 29,011 shares of company stock valued at $4,575,097 over the last ninety days. Corporate insiders own 1.40% of the company’s stock.

CLX has been the topic of several recent analyst reports. Wells Fargo & Co reiterated a “hold” rating and issued a $153.00 price target on shares of Clorox in a research note on Thursday, August 1st. Morgan Stanley boosted their price target on Clorox from $141.00 to $144.00 and gave the stock an “underweight” rating in a research note on Friday, August 2nd. Citigroup set a $156.00 price target on Clorox and gave the stock a “hold” rating in a research note on Thursday, May 23rd. Argus cut Clorox from a “buy” rating to a “hold” rating in a research note on Monday, May 20th. Finally, Royal Bank of Canada boosted their price target on Clorox to $161.00 and gave the stock a “sector perform” rating in a research note on Friday, August 2nd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $154.07.

Shares of NYSE:CLX traded down $3.22 during trading on Friday, hitting $155.93. 647,503 shares of the company traded hands, compared to its average volume of 1,061,413. The stock has a market capitalization of $19.88 billion, a price-to-earnings ratio of 24.67, a PEG ratio of 4.97 and a beta of 0.37. The business’s fifty day moving average is $159.51 and its 200-day moving average is $155.89. Clorox Co has a one year low of $141.53 and a one year high of $167.70. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The company had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The business’s revenue was down 3.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.66 earnings per share. On average, analysts forecast that Clorox Co will post 6.4 EPS for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: The primary rules of Elliott Wave theory

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.